Literature DB >> 30495992

Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US-Mexico Border.

David Goodman-Meza1, Maria Elena Medina-Mora1, Carlos Magis-Rodríguez1, Raphael J Landovitz1, Steve Shoptaw1, Dan Werb1.   

Abstract

In North America, opioid use and its harms have increased in the United States and Canada over the past 2 decades. However, Mexico has yet to document patterns suggesting a higher level of opioid use or attendant harms.Historically, Mexico has been a country with low-level use of opioids, although heroin use has been documented. Low-level opioid use is likely attributable to structural, cultural, and individual factors. However, a range of dynamic factors may be converging to increase the use of opioids: legislative changes to opioid prescribing, national health insurance coverage of opioids, pressure from the pharmaceutical industry, changing demographics and disease burden, forced migration and its trauma, and an increase in the production and trafficking of heroin. In addition, harm-reduction services are scarce.Mexico may transition from a country of low opioid use to high opioid use but has the opportunity to respond effectively through a combination of targeted public health surveillance of high-risk groups, preparation of appropriate infrastructure to support evidence-based treatment, and interventions and policies to avoid a widespread opioid use epidemic.

Entities:  

Mesh:

Year:  2018        PMID: 30495992      PMCID: PMC6301408          DOI: 10.2105/AJPH.2018.304767

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  79 in total

1.  Opioid availability in Latin America as a global problem: a new strategy with regional and national effects.

Authors:  Liliana De Lima
Journal:  J Palliat Med       Date:  2004-02       Impact factor: 2.947

2.  Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI).

Authors:  J Cleary; L De Lima; J Eisenchlas; L Radbruch; J Torode; N I Cherny
Journal:  Ann Oncol       Date:  2013-12       Impact factor: 32.976

3.  Prescription opioid analgesic use among adults: United States, 1999-2012.

Authors:  Steven M Frenk; Kathryn S Porter; Leonard J Paulozzi
Journal:  NCHS Data Brief       Date:  2015-02

4.  Educational Outreach to Opioid Prescribers: The Case for Academic Detailing.

Authors:  Margot Trotter Davis; Brian Bateman; Jerry Avorn
Journal:  Pain Physician       Date:  2017-02       Impact factor: 4.965

5.  The devil (and drugs) in the details: Portugal's focus on public health as a model for decriminalization of drugs in Mexico.

Authors:  Kellen Russoniello
Journal:  Yale J Health Policy Law Ethics       Date:  2012

6.  Integrated oncology and palliative care: five years experience at the National Cancer Institute of Mexico.

Authors:  Silvia Allende-Pérez; Emma Verástegui-Avilés; Alejandro Mohar-Betancourt; Abelardo Meneses-García; Angel Herrera-Gómez
Journal:  Salud Publica Mex       Date:  2016-04

7.  Mexico's evolving HIV epidemic.

Authors:  Steffanie A Strathdee; Carlos Magis-Rodriguez
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

8.  Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims.

Authors:  Patrick D Quinn; Kwan Hur; Zheng Chang; Erin E Krebs; Matthew J Bair; Eric L Scott; Martin E Rickert; Robert D Gibbons; Kurt Kroenke; Brian M D'Onofrio
Journal:  Pain       Date:  2017-01       Impact factor: 7.926

9.  Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.

Authors:  Amos Irwin; Ehsan Jozaghi; Brian W Weir; Sean T Allen; Andrew Lindsay; Susan G Sherman
Journal:  Harm Reduct J       Date:  2017-05-12

10.  History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA.

Authors:  Maria Luisa Mittal; Devesh Vashishtha; Shelly Sun; Sonia Jain; Jazmine Cuevas-Mota; Richard Garfein; Steffanie A Strathdee; Dan Werb
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-10-03
View more
  7 in total

1.  Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.

Authors:  Lindsay Fox; Lewis S Nelson
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

2.  Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico.

Authors:  Jeanette M Bowles; Sonia Jain; Xiaoying Sun; Steffanie A Strathdee; Kora DeBeck; M-J Milloy; Zachary Bouck; Dan Werb
Journal:  Int J Drug Policy       Date:  2021-08-12

Review 3.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

4.  The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana.

Authors:  Joseph Friedman; Philippe Bourgois; Morgan Godvin; Alfonso Chavez; Lilia Pacheco; Luis A Segovia; Leo Beletsky; Jaime Arredondo
Journal:  Int J Drug Policy       Date:  2022-04-11

5.  "Another Person Was Going to Do It": The Provision of Injection Drug Use Initiation Assistance in a High-Risk U.S.-Mexico Border Region.

Authors:  Maria L Mittal; Andrew Guise; Claudia Rafful; Patricia Gonzalez-Zuñiga; Peter Davidson; Devesh Vashishtha; Steffanie A Strathdee; Dan Werb
Journal:  Subst Use Misuse       Date:  2019-08-07       Impact factor: 2.164

6.  Sex differences in the multilevel determinants of injection risk behaviours among people who inject drugs in Tijuana, Mexico.

Authors:  Jennifer P Jain; Steffanie A Strathdee; Brooke S West; Patricia Gonzalez-Zuniga; Gudelia Rangel; Eileen V Pitpitan
Journal:  Drug Alcohol Rev       Date:  2020-08-14

7.  Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts.

Authors:  Meyers Sa; Rafful C; Mittal Ml; Smith Lr; Tirado-Muñoz J; Jain S; Sun X; Garfein Rs; Strathdee Sa; DeBeck K; Hayashi K; McNeil R; Milloy Mj; Olding M; Guise A; Werb D; Scheim Ai
Journal:  Int J Drug Policy       Date:  2020-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.